Policy News
CY 2025 Medicare Physician Fee Schedule Final Rule Summary
On November 1, the Centers for Medicare & Medicaid Services (CMS) released the Medicare Physician Fee Schedule (MPFS) final rule for Calendar Year (CY) 2025 (CMS-1807-F). The rule updates payment policies and rates for Part B services furnished u...
Read moreFY 2025 Medicare Inpatient Prospective Payment System Final Rule
On August 1, the Centers for Medicare & Medicaid Services (CMS) released the Inpatient Prospective Payment System (IPPS) final rule (CMS-1808-F) for FY 2025. This rule updates payment policies and payment rates for acute care inpatient hospital s...
Read moreFY 2025 Medicare Inpatient Prospective Payment System Proposed Rule Summary
On April 10, the Centers for Medicare & Medicaid Services (CMS) released the Inpatient Prospective Payment System (IPPS) proposed rule (CMS-1808-P) for FY 2025. This rule updates payment policies and payment rates for acute care inpatient hospita...
Read moreAllogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome
On March 6, the Centers for Medicare & Medicaid Services (CMS) released a final National Coverage Determination (NCD) for Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Myelodysplastic Syndromes (MDS), which was effective upon its...
Read moreHealth Data Technology and Interoperability Final Rule Summary
On January 9, the Office of the National Coordinator for Health Information Technology (ONC) and the Department of Health and Human Services published a final rule for Health Data, Technology, and Interoperability: Certification Program Updates, Algo...
Read moreAdvancing Interoperability and Improving the Prior Authorization Process Final Rule
On January 17, the Centers for Medicare & Medicaid Services (CMS) released a final rule that outlines policy changes to the prior authorization (PA) process for Medicare Advantage (MA) organizations, state Medicaid and Children鈥檚 Health Insurance...
Read more2023 ASH Advocacy Efforts to Ensure Patient Access to Care
During 2023, ASH continued to be highly visible in our advocacy on issues that ensure patient access to affordable health care, including blood donor diversity, maternal health and hematology, drug shortage issues, and access to cell and gene therapi...
Read more2023 ASH Advocacy Efforts Related to Sickle Cell Disease
In 2023, ASH was actively advocating for issues impacting hematology research and practice, including research and public health funding, access to quality care for patients, physician payment and coverage for hematologists, and policy issues related...
Read more2023 Year-End Physician Practice Advocacy Highlights
ASH continues to advocate for issues impacting physician practice including workforce, coding issues, coverage and reimbursement, prior authorization, telehealth, and drug shortage issues. During 2023, ASH was very busy working with Congress and the...
Read more2023 91国产精品 and Public Health Funding Advocacy Highlights
ASH continues to advocate for issues impacting hematology research and practice, including research and public health funding, access to quality care for patients, physician payment and coverage for hematologists, and policy issues related to sickle...
Read more- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10